Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation
US6025339A · kind A · utility
17Cited by
4References
77Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 26, 1996 |
| Grant date | Feb 15, 2000 |
| Priority date | — |
| Expiry date | Nov 26, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of reducing bronchoconstriction in a subject in need of such treatment is disclosed. The method comprises administering to the subject an antisense oligonucleotide molecule directed against the A.sub.1 or A.sub.3 adenosine receptor in an amount effective to reduce bronchoconstriction. The method is useful for treating patients afflicted with asthma. Pharmaceutical formulations are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.